GlassScriptPhysician profile
Kin Y Lam
NPI 1962442699
$104,755.17
in general payments reported to CMS, 2019-2025
100 companies · $12K in 2025
The $12K reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $20K · 2021: $8,728 · 2022: $17K · 2023: $12K · 2024: $9,240 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27K · Consulting Fee: $4,345 · Education: $987 · Long Term Medical Supply Or Device Loan: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27,313.28 |
| Consulting Fee | $4,345.00 |
| Education | $986.61 |
| Long Term Medical Supply Or Device Loan | $299.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $27,211.23 | 2019-2025 | Tagrisso, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $8,800.30 | 2019-2025 | Gilotrif, Jardiance |
| Exelixis INC. | $5,393.04 | 2019-2025 | Cabometyx |
| E.R. Squibb & Sons, L.L.C. | $4,716.16 | 2019-2025 | Opdivo, Reblozyl, Opdualag |
| Novartis Pharmaceuticals Corporation | $3,546.24 | 2019-2025 | |
| Eisai INC. | $3,281.62 | 2019-2025 | |
| Pfizer INC. | $3,198.21 | 2019-2025 | |
| Glaxosmithkline, LLC. | $2,972.71 | 2019-2025 | Trelegy Ellipta, Ojjaara, Jemperli |
| Janssen Biotech, INC. | $2,775.33 | 2019-2025 | Rybrevant, Darzalex, Erleada |
| Merck Sharp & Dohme LLC | $2,600.97 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Taiho Oncology, INC. | $2,395.79 | 2019-2025 | |
| Amgen INC. | $2,271.50 | 2019-2025 | Lumakras, Evenity, Imdelltra (Amg757) |
| Gilead Sciences, INC. | $1,946.34 | 2019-2025 | Trodelvy |
| Kite Pharma, INC. | $1,758.34 | 2019-2023 | Yescarta |
| Celgene Corporation | $1,701.45 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,609.52 | 2020-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $1,580.52 | 2019-2025 | |
| Lilly USA, LLC | $1,579.01 | 2019-2025 | Verzenio, Jaypirca, Jardiance |
| Daiichi Sankyo INC. | $1,467.76 | 2020-2025 | Enhertu, Datroway, Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $1,383.14 | 2019-2025 | Fruzaqla, Ninlaro, Alunbrig |
| Rigel Pharmaceuticals, INC. | $1,367.37 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Bayer Healthcare Pharmaceuticals INC. | $1,247.64 | 2019-2025 | |
| Astellas Pharma US INC | $1,240.13 | 2019-2025 | Xtandi, Vyloy, Xospata |
| Janssen Scientific Affairs, LLC | $1,117.39 | 2025 | Rybrevant |
| Genzyme Corporation | $1,024.98 | 2019-2025 | |
| Seagen INC. | $1,010.16 | 2019-2025 | Tukysa, Padcev, Adcetris |
| Puma Biotechnology, INC. | $930.08 | 2019-2025 | Nerlynx |
| Incyte Corporation | $737.41 | 2019-2025 | Monjuvi, Pemazyre, Jakafi |
| Array Biopharma INC | $687.68 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Sobi, INC | $604.12 | 2022-2025 | |
| Beigene USA, INC. | $562.00 | 2022-2025 | Brukinsa, Tevimbra |
| Emd Serono, INC. | $558.14 | 2019-2024 | Tepmetko, Bavencio |
| Amarin Pharma, INC. | $550.79 | 2019-2023 | |
| Mirati Therapeutics, INC. | $530.57 | 2023-2024 | Krazati |
| Genentech USA, INC. | $453.01 | 2019-2025 | Tecentriq, Rozlytrek, Alecensa |
| Beone Medicines USA, INC. | $430.76 | 2025 | Tevimbra, Brukinsa |
| Stemline Therapeutics INC. | $376.41 | 2023-2025 | Orserdu |
| Exact Sciences Corporation | $370.46 | 2023-2025 | Cologuard Collection Kit |
| Athenex Pharmaceutical Division, LLC | $350.00 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $347.65 | 2019-2025 | Zoryve, Livalo |
| Dova Pharmaceuticals | $342.41 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $341.00 | 2020-2025 | Zepzelca |
| Myriad Genetic Laboratories, INC. | $331.74 | 2021-2024 | Myrisk, Precisetumor |
| Horizon Therapeutics Plc | $314.24 | 2020-2023 | Krystexxa |
| Foundation Medicine, INC. | $309.16 | 2020-2023 | |
| Clovis Oncology, INC. | $302.40 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $290.85 | 2019-2025 | Ultomiris |
| Regeneron Healthcare Solutions, INC. | $284.07 | 2019-2025 | Libtayo |
| Deciphera Pharmaceuticals INC. | $280.22 | 2020-2025 | Qinlock, Romvimza, Tgct |
| Agios Pharmaceuticals, INC. | $261.53 | 2024-2025 | Pyrukynd |
| Opko Pharmaceuticals, LLC | $251.95 | 2019-2022 | |
| Comsort, INC | $250.00 | 2019 | |
| Intra-Sana Laboratories | $200.00 | 2022 | |
| Novocure Gmbh | $200.00 | 2022 | |
| Myovant Sciences INC. | $197.26 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $186.03 | 2019-2021 | |
| Aveo Pharmaceuticals, INC. | $185.24 | 2024-2025 | |
| Tempus Ai, INC | $169.71 | 2024-2025 | Xt Cdx |
| Accord Healthcare, INC. | $162.50 | 2025 | |
| Sumitomo Pharma America, INC. | $159.80 | 2023-2025 | Gemtesa, Orgovyx |
| Acrotech Biopharma INC. | $157.09 | 2021-2025 | Beleodaq |
| Arbor Pharmaceuticals, INC. | $136.52 | 2019-2021 | |
| Tesaro, INC. | $125.19 | 2019 | |
| Insmed, INC. | $123.75 | 2019-2025 | Brinsupri, Arikayce |
| Janssen Pharmaceuticals, INC | $120.21 | 2019-2021 | |
| Karyopharm Therapeutics INC. | $117.20 | 2024-2025 | Xpovio |
| Verastem, INC. | $104.78 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $104.09 | 2019-2023 | Imbruvica |
| Recordati_rare_diseases_inc. | $93.47 | 2023-2025 | Sylvant |
| Ipsen Biopharmaceuticals, INC | $88.26 | 2022-2024 | Tazverik, Onivyde, Somatuline Depot |
| Verity Pharmaceuticals INC. | $84.98 | 2023-2024 | Trelstar |
| Allergan, INC. | $84.12 | 2019 | |
| Sanofi-Aventis U.S. LLC | $83.71 | 2019-2021 | |
| Akebia Therapeutics INC | $83.58 | 2019-2022 | |
| Blueprint Medicines Corporation | $81.66 | 2020 | |
| Sanofi Pasteur INC. | $74.37 | 2019-2020 | |
| Ibsa Pharma INC. | $71.40 | 2021 | |
| Novocure INC. | $69.14 | 2023-2025 | Optune Lua (Novottf-200t), Optune Lua (Novottf-200t) |
| Advanced Accelerator Applications | $67.79 | 2020 | |
| Tersera Therapeutics LLC | $65.70 | 2023-2025 | Zoladex |
| Teva Pharmaceuticals USA, INC. | $61.02 | 2019 | |
| Azurity Pharmaceuticals, INC. | $59.59 | 2025 | Danziten |
| Genmab U.S., INC. | $56.14 | 2023-2024 | Epkinly |
| Nestle Healthcare Nutrition INC. | $54.55 | 2022 | |
| Kyowa Kirin, INC. | $52.31 | 2019 | |
| Shionogi INC | $51.00 | 2019 | |
| Hikma Pharmaceuticals USA | $45.96 | 2019-2020 | |
| Geron Corporation | $43.03 | 2025 | Rytelo |
| Springworks Therapeutics, INC. | $41.00 | 2024-2025 | Gomekli, Ogsiveo |
| Eusa Pharma (US) LLC | $40.37 | 2022 | |
| Acceleron Pharma, INC. | $39.82 | 2020 | |
| Epizyme, INC. | $38.44 | 2020-2022 | |
| Secura Bio, INC. | $38.06 | 2019-2024 | Copiktra |
| Coherus Oncology, INC. | $34.48 | 2022 | |
| Chiesi USA, INC. | $29.99 | 2024 | Mycapssa |
| Adc Therapeutics America, INC. | $27.87 | 2025 | |
| Servier Pharmaceuticals LLC | $25.03 | 2022 | |
| Pharmacosmos Therapeutics INC. | $24.99 | 2024 | Cosela |
| Sun Pharmaceutical Industries INC. | $24.17 | 2021 | |
| Invivyd INC | $23.44 | 2025 | Pemgarda |
Drugs and devices associated with these payments
Lonsurf $2,307Rybrevant $1,569Tavalisse $1,021Lenvima $973Enhertu $952Rezlidhia $944Keytruda $935Reblozyl $878Opdivo $870Ozempic $710Tukysa $667Rybelsus $665Tagrisso $615Kisqali $610Xtandi $592Krazati $553Cabometyx $551Trelegy Ellipta $540Brukinsa $519Doptelet $456Ibrance $451Lynparza $450Braftovi $436Pomalyst $390Darzalex $387Orserdu $376Cologuard Collection Kit $370Inlyta $370Mektovi $370Scemblix $370Comirnaty $339Erleada $338Ojjaara $331Tevimbra $331Lorbrena $327Prevnar 20 $322Abrysvo $322Monjuvi $299Fruzaqla $298Farxiga $297Tecvayli $295Talzenna $294Balversa $289Gavreto $288Verzenio $288Stivarga $272Vitrakvi $272Akeega $265Imbruvica $261Myrisk $255Padcev $251Datroway $244Jardiance $241Jemperli $233Epkinly $225Nubeqa $216Pyrukynd $211Zejula $210Qinlock $207Talvey $207Breztri $205Bavencio $196Ninlaro $194Fabhalta $194Jaypirca $193Orgovyx $190Zepzelca $187Fotivda $185Libtayo $180Trodelvy $170Piqray $168Tepmetko $166Sarclisa $165Camcevi $163Kerendia $160Lumakras $160Nerlynx $159Vyloy $159Opdualag $156Creon $141Beleodaq $139Airsupra $135Evenity $131Prolia $131Xt Cdx $128Imdelltra (Amg757) $127Pemazyre $123Gilotrif $118Adcetris $117Xpovio $117Welireg $116Elrexfio $115Gemtesa $114Inqovi $107Mounjaro $106Zepbound $106Xalkori $100Brinsupri $100Bosulif $94.10Sylvant $93.47
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kin Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.